Antibiotics pp 102-116 | Cite as


  • D. C. Jordan
  • P. E. Reynolds


The antibiotic, vancomycin, was isolated in the Eli Lilly Company laboratories from a Streptomyces species found in soil obtained in Borneo and India. This organism, which is also found in domestic soils, has been described by Pittenger and Brigham (1956), who the named it Streptomyces orientalis. The hydrochloride of this antibiotic bears the trade name Vancocin.


Bacillus Megaterium Cell Wall Synthesis Teichoic Acid Vancomycin Therapy Vancomycin Concentration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Anderson, J. S., M. Matsuhashi, M. A. Haskin, and J. L. Strominger: Lipidphosphoacetylmuramyl-pentapeptide and lipid-phosphodisaccharide-pentapeptide: presumed membrane transport intermediates in cell wall synthesis. Proc. Natl. Acad. Sci. U.S. 53, 881 (1965).CrossRefGoogle Scholar
  2. Anderson, R. C., H. M. Worth, P. N. Harris, and K. K. Chen: Vancomycin, a new antibiotic. IV. Pharmacologic and toxicologic studies. Antibiotics Ann. 1956/57, 75 (1957).Google Scholar
  3. Best, G. K., and N. N. Durham: Effect of vancomycin on Bacillus subtilis. Arch. Biochem. Biophys. 105, 120 (1964).PubMedCrossRefGoogle Scholar
  4. Best, G. K., and N. N. Durham: Vancomycin adsorption to Bacillus subtilis cell walls. Arch. Biochem. Biophys. 111, 685 (1965).PubMedCrossRefGoogle Scholar
  5. Boyle, A. M., and R. M. Price: Vancomycin prevents crown gall. Phytopathology 53, 1272 (1963).Google Scholar
  6. Brock, T. D.: Effect of antibiotics and inhibitors on M protein synthesis. J. Bacteriol. 85, 527 (1963).PubMedGoogle Scholar
  7. Burger, M. M., and L. Glaser: The synthesis of teichoic acids. I. Polyglycerophosphate. J. Biol. Chem. 239, 3168 (1964).Google Scholar
  8. Chatterjee, A. N., and J. T. Park: Biosynthesis of cell wall mucopeptide by a particulate fraction from Staphylococcus aureus. Proc. Natl. Acad. Sci. U.S. 51, 9 (1964).CrossRefGoogle Scholar
  9. Daikos, G. K., M. Athanasiadou U. E. Papadakis: Empfindlichkeit pathogener Staphylokokken and gramnegativer Bakterien gegenüber Vancomycin and anderen Antibiotica. Arch. Mikrobiol. 35, 248 (1960).PubMedCrossRefGoogle Scholar
  10. Day, L. E., and R. N. CosTilow: Studies on the sporulation of Clostridium botulinum 62-A. Bacteriol. Proc. 75 (1961).Google Scholar
  11. Durham, N. N.: Inhibition of microbial growth and separation by D-serine, vancomycin and mitomycin C. J. Bacteriol. 86, 380 (1963).PubMedGoogle Scholar
  12. Dutton, A. A. C., and P. C. Elmes: Vancomycin: Report on treatment of patients with severe staphylococcal infections. Brit. Med. J. 1959 I, 1144.CrossRefGoogle Scholar
  13. Ehrenkranz, N. J.: The clinical evaluation of vancomycin in treatment of multi-antibiotic refractory staphylococcal infections. Antibiotics Ann. 1958/59, 587 (1959).Google Scholar
  14. Fairbrother, R. W., and B. L. Williams: Two new antibiotics. Antibacterial activity of novobiocin and vancomycin. Lancet 1956 II, 1177.CrossRefGoogle Scholar
  15. Garrod, L. P., and P. M. Waterworth: Behaviour in vitro of some new antistaphyloccal antibiotics. Brit. Med. J. 1956 II, 61.CrossRefGoogle Scholar
  16. Geraci, J. E., F. R. Heilman, D. R. Nichols, and W. E. Wellman: Antibiotic therapy of bacterial endocarditis. Vii. Vancomycin for acute micrococcal endocarditis. Proc. Mayo Clinic 33, 172 (1958).Google Scholar
  17. Geraci, J. E., F. R. Heilman, D. R. Nichols, W. E. Wellman, and G. T. Ross: Some laboratory and clinical experiences with a new antibiotic, vancomycin. Antibiotics Ann. 1956/57, 90 (1957).Google Scholar
  18. Glaser, L.: The synthesis of teichoic acids. II. Polyribitol phosphate. J. Biol. Chem. 239, 3178 (1964).PubMedGoogle Scholar
  19. Griffith, R. A., and F. B. Peck, JR.: Vancomycin, a new antibiotic. Iii. Preliminary clinical and laboratory studies. Antibiotics Ann. 1955/56, 619 (1956).Google Scholar
  20. Hanawalt, P.: Use of phosphorus-32 in microassay for nucleic acid synthesis inGoogle Scholar
  21. Escherichia coli. Science 130, 386 (1959).CrossRefGoogle Scholar
  22. Hancock, R., and P. C. Fitz- James: Some differences in the action of penicillin, bacitracin, and vancomycin on Bacillus megaterium. J. Bacteriol. 87, 1044 (1964).PubMedGoogle Scholar
  23. Hash, J. H.: Formation of Staphylococcus aureus protoplasts by enzymes from Chalaropsis sp. Federation Proc. 21, 248 (1962).Google Scholar
  24. Higgins, H. M., W. H. Harrison, G. M. Wild, H. R. Bungay, and M. H. McCoRMlcx: Vancomycin: A new antibiotic. VI. Purification and properties of vancomycin. Antibiotics Ann. 1957/58, 906 (1958).Google Scholar
  25. Innis, W.: Studies on possible modes of action of a new antibiotic (vancomycin) on strains of Staphylococcus aureus. M. S.A. Thesis, University of Toronto 1959.Google Scholar
  26. Jordan, D. C.: Effect of vancomycin on the synthesis of the cell wall mucopeptide of Staphylococcus aureus. Biochem. Biophys. Research Commun. 6, 167 (1961)CrossRefGoogle Scholar
  27. Jordan, D. C.: Effect of vancomycin on the synthesis of the cell wall and cytoplasmic membrane of Staphylococcus aureus. Can. J. Microbiol. 11, 390 (1965).PubMedCrossRefGoogle Scholar
  28. Jordan, D. C., and W. Inniss: Selective inhibition of ribonucleic acid synthesis in Staphylococcus aureus by vancomycin. Nature 184, 1894 (1959).PubMedCrossRefGoogle Scholar
  29. Jordan, D. C., and W. Inniss: Mode of action of vancomycin on Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 1961, p. 218 (1962).Google Scholar
  30. Jordan, D. C., and H. D. C. Mallory: Site of action of vancomycin on Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 1964, p. 489 (1965).Google Scholar
  31. Kagen, B. M., C. W. Molander, S. Zolla, E. M. Heimlich, H. J. Weinberger, R. Busser, and S. Liepnieks: Antibiotic sensitivity and pathogenicity of L-phase variants of staphylococci. Antimicrobial Agents and Chemotherapy 1963, p. 517 (1964).Google Scholar
  32. Kavanagh, F.: Vancomycin. In: F. Kavanagh (ed.), Analytical microbiology, p. 375. New York: Academic Press Inc. 1963.Google Scholar
  33. Kirby, W. M. M.: Vancomycin therapy of staphylococcal infections. Antibiotics, Chemotherapy 11, 84 (1963).Google Scholar
  34. Kirby, W. M. M., and C. L. Divelbiss: Vancomycin, clinical and laboratory studies. Antibiotics Ann. 1956/57, 107 (1957).Google Scholar
  35. Kirby, W. M. M., D. M. Perry, and J. L. Lane: Present status of vancomycin therapy of staphylococcal and streptococcal infections. Antibiotics Ann. 1958/59, 580 (1959).Google Scholar
  36. Lee, C. C., and R. C. Anderson: Toxicologic studies on vancomycin and polyethylene glycol 200. Toxicol. Appl. Pharmacol. 4, 206 (1962).PubMedCrossRefGoogle Scholar
  37. Lee, C. C., R. C. Anderson, and K. K. Chen: Vancomycin, a new antibiotic. V. Distribution, excretion, and renal clearance. Antibiotics Ann. 1956/57, 82 (1957).Google Scholar
  38. Louria, D. B., T. Kaminski, and J. Buchanan: Vancomycin in severe staphylococcalGoogle Scholar
  39. infections. A.M.A. Arch. Internal Med. 107, 225 (1961).CrossRefGoogle Scholar
  40. Mccarthy, C., and M. L. Snyder: Selective medium for Fusobacterium and Leptospira. J. Bacteriol. 86, 158 (1963).PubMedGoogle Scholar
  41. Mccormick, M. H., W. M. Stark, G. E. Pittenger, R. C. Pittenger, and J. M. McGuIre: Vancomycin, a new antibiotic. I. Chemical and biologic properties. Antibiotics Ann. 1955/56, 606 (1956).Google Scholar
  42. Mallory, H. D. C.: Further studies on the effects of vancomycin on Staphylococcus aureus. M.S.A. Thesis, University of Toronto 1963.Google Scholar
  43. Marshall, F. J.: Structure studies on vancomycin. J. Med. Chem. 8, 18 (1965).PubMedCrossRefGoogle Scholar
  44. Matsuhashi, M., C. P. Dietrich, and J. L. Strominger: Incorporation of glycine into the cell wall glycopeptide in Staphylococcus aureus: role of sRna and lipid intermediates. Proc. Natl. Acad. Sci. U.S. 54, 587 (1965).CrossRefGoogle Scholar
  45. Meadow, P. M., J. S. Anderson, and J. L. Strominger: Enzymatic polymerization of Udp-acetylmuramyl. L-ala. D-glu. L-lys. D-ala. D-ala and Udp-acetylglucosamine by a particulate enzyme from Staphylococcus aureus and its inhibition by antibiotics. Biochem. Biophys. Research Commun. 14, 382 (1964).CrossRefGoogle Scholar
  46. Mehta, P. P., D. Gottlieb, and D. Powell: Vancomycin, a potential agent for plant disease prevention. Phytopathology 49, 177 (1959).Google Scholar
  47. Molander, C. W., B. M. Kagan, H. J. Weinberger, E. M. Heimlich, and R. J. BussER: Induction by antibiotics and comparative sensitivity of L-phase variants of Staphylococcus aureus. J. Bacteriol. 88, 591 (1964).PubMedGoogle Scholar
  48. Nishimura, H., S. Okamoto, K. Nakajima, M. Shimohira, and N. Simaoka: Studies on vancomycin. I. Physical, chemical properties and in vitro antibacterial studies. Shionogi’s Ann. Rep. 7, 465 (1957).Google Scholar
  49. Park, J. T., and R. Hancock: A fractionation procedure for studies on the synthesis of cell wall mucopeptide and of other polymers in cells of Staphylococcus aureus. J. Gen. Microbiol. 22, 249 (1960).PubMedCrossRefGoogle Scholar
  50. Park, J. T., and J. L. Strominger: Mode of action of penicillin. Science 125, 99 (1957).PubMedCrossRefGoogle Scholar
  51. Pittenger, R. C., and R. B. Brigham: Streptomyces orientalis n. sp., the source of vancomycin. Antibiotics, Chemotherapy 6, 642 (1956).Google Scholar
  52. Reynolds, P. E.: Studies on the mode of action of vancomycin. Biochim. et Biophys. Acta 52, 403 (1961).Google Scholar
  53. Reynolds, P. E.: A comparative study of the effects of penicillin and vancomycin. Biochem. J. 84, 99P (1962).Google Scholar
  54. Reynolds, P. E.: Mucopeptide synthesis in Staphylococcus aureus after treatment with vancomycin. J. Gen. Microbiol. 35, IT (1964a).Google Scholar
  55. Reynolds, P. E.: The mode of action of vancomycin. Ph. D thesis, University of Cambridge 1964 b.Google Scholar
  56. Reynolds, P. E.: Antibiotics affecting cell wall synthesis. In: Sixteenth Symposium of the Society for General Microbiology 1965 (to be published).Google Scholar
  57. Rogers, H. J.: The bacterial cell wall. The result of absorption, structure or selective permeability. J. Gen. Microbiol. 32, 19 (1963).PubMedCrossRefGoogle Scholar
  58. Rogosa, M., R. J. Fitzgerald, M. E. Macintosh, and A. J. Buchanan: Improved medium for selective isolation of Veillonella. J. Bacteriol. 76, 455 (1958).PubMedGoogle Scholar
  59. Russell, A. D.: Mode of action of vancomycin. J. Pharm. and Pharmacol. 16, 37 (1964).Google Scholar
  60. Schneierson, S. S., and D. Amsterdam: In vitro sensitivity of erythromycin-resistant strains of staphylococci and enterococci to vancomycin and novobiocin. Antibiotics, Chemotherapy 7, 251 (1957).Google Scholar
  61. Shockman, G. D., and J. O. Lampen: Inhibition by antibiotics of the growth of bacterial and yeast protoplasts. J. Bacteriol. 84, 508 (1962).PubMedGoogle Scholar
  62. Struve, W. G., and F. C. Neuhaus: Evidence for an initial acceptor of Udp-NAcmuramyl-pentapeptide in the synthesis of bacterial mucopeptide. Biochem. Biophys. Research Commun. 18, 6 (1965).CrossRefGoogle Scholar
  63. Tipper, D. J., J. L. Strominger, and J.-M. Ghuysen: Staphylolytic enzyme from Chalaropsis: mechanism of action. Science 146, 781 (1964).PubMedCrossRefGoogle Scholar
  64. Waisbren, B. A., and C. L. Strelitzer: A five year study of the antibiotic sensitivities and cross resistance of staphylococci in a general hospital. Antibiotics Ann. 1957/58, 350 (1958).Google Scholar
  65. Williams, R. E. O.: L forms of Staphylococcus aureus. J. Gen. Microbiol. 33, 325 (1963).PubMedCrossRefGoogle Scholar
  66. Yudkin, M. D.: The effect of penicillin, novobiocin, streptomycin and vancomycin on membrane synthesis by protoplasts of Bacillus megaterium. Biochem. J. 89, 290 (1963).PubMedGoogle Scholar
  67. Ziegler, D. W., R. N. Wolfe, and J. M. McGuIre: Vancomycin, a new antibiotic. II. In vitro antibacterial studies. Antibiotics Ann. 1955/56, 612 (1956).Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1967

Authors and Affiliations

  • D. C. Jordan
  • P. E. Reynolds

There are no affiliations available

Personalised recommendations